Cromwell Holdings LLC Grows Holdings in CVS Health Corporation $CVS

Cromwell Holdings LLC raised its position in CVS Health Corporation (NYSE:CVS) by 244.3% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,185 shares of the pharmacy operator’s stock after buying an additional 2,260 shares during the period. Cromwell Holdings LLC’s holdings in CVS Health were worth $220,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. Bell Investment Advisors Inc increased its holdings in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares in the last quarter. Roxbury Financial LLC increased its holdings in CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after buying an additional 202 shares in the last quarter. ORG Partners LLC grew its position in shares of CVS Health by 418.9% in the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 377 shares during the period. Saudi Central Bank acquired a new stake in shares of CVS Health in the first quarter valued at about $34,000. Finally, Livelsberger Financial Advisory acquired a new stake in shares of CVS Health in the second quarter valued at about $35,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Insider Activity

In other news, Director Anne A. Finucane sold 7,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. The trade was a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 1.22% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research analyst reports. Bernstein Bank dropped their target price on shares of CVS Health from $78.00 to $72.00 and set a “market perform” rating on the stock in a research report on Wednesday, July 16th. Zacks Research lowered shares of CVS Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 8th. Sanford C. Bernstein lifted their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research report on Friday, September 5th. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Finally, Morgan Stanley boosted their price target on shares of CVS Health from $80.00 to $82.00 and gave the stock an “overweight” rating in a research report on Friday, August 1st. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $78.25.

CVS Health Stock Performance

NYSE:CVS opened at $77.48 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.80 and a quick ratio of 0.62. The firm has a market capitalization of $98.27 billion, a price-to-earnings ratio of 21.64, a PEG ratio of 0.85 and a beta of 0.60. The company’s 50-day moving average is $70.37 and its two-hundred day moving average is $67.27. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $77.76.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business’s revenue was up 8.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health’s payout ratio is 74.30%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.